ABCG2 and renal carcinoma: In renal cancer cell lines, aberrant promoter methylation of the ABCG2 gene was shown (27) and multiple SNPs have been reported in patients with renal cancer (28), but no direct analyis of tumor tissue samples or a direct association with resistance to tyrosine kinase inhibitors has been reported.